COMPANY
Angimmune
Angimmune is working in conjunction with these researchers on developing a clinical protocol to prevent antibody-mediated rejection post kidney transplantation. From company website Source · Oct 13, 2026
COMPANY
Angimmune is working in conjunction with these researchers on developing a clinical protocol to prevent antibody-mediated rejection post kidney transplantation. From company website Source · Oct 13, 2026